These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1223674

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
    Hunyi L.
    Ther Hung; 1978; 26(2):77-80. PubMed ID: 684660
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans.
    Roztocil K, Oliva J, Linhart J, Prerovský I, Modr Z.
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):135-8. PubMed ID: 844932
    [Abstract] [Full Text] [Related]

  • 12. [Piribedil (TF 871) in the treatment of arteriopathies of the lower extremities].
    Argenteri A, Moia R, Negri L.
    Ann Ital Chir; 1979 Mar; 51(2):145-55. PubMed ID: 554489
    [No Abstract] [Full Text] [Related]

  • 13. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G, Pitea P, Blaj A.
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985 Mar; 34(3):207-13. PubMed ID: 2931752
    [No Abstract] [Full Text] [Related]

  • 14. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L, Boeri S, Ricci G.
    Minerva Cardioangiol; 1974 Mar; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
    Prokhorov GG, Potapov VV, Ogneva NS, Zybina NN.
    Vestn Khir Im I I Grek; 1994 Mar; 152(1-2):30-4. PubMed ID: 7701736
    [Abstract] [Full Text] [Related]

  • 17. [Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].
    Lucero Eseverri JA, Fajardo JD, Velles Aguirre L, Quijano E, Ciliberti E, Lucarelli R.
    Prensa Med Argent; 1970 Apr 24; 57(8):394-8. PubMed ID: 5517707
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Human chorionic gonadotropin in the treatment of chronic peripheral obliterative arteriosclerotic arteriopathies of the lower limbs].
    Bagliani A, Moia R.
    Minerva Med; 1978 Apr 21; 69(19):1287-93. PubMed ID: 662155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.